24^th Global Nephrology, Urology and Kidney Failure Congress

Levent Yucetin is the director of Antalya Medicalpark Transplant Center Coordination. He studied and trained in Oxford, Cambridge, Harefield transplant centers, Barcelona University and TPM organisation between 1999-2001. He was the president of Turkish Transplant Coordinator\'s Society between 2005-2009, National Key Member of ETCO between 2002-2012. Turkey\'s leader at European Union projects ETPOD,ELIPSY,LIDOPS and ODEQUS. Member of Turkish Health Ministery\'s Transplant Coordinators and Organ Donation board. Trainer of Transplant coordinators at Helath Ministery Certification organisation. He has published more than 29 papers in reputed journals and 10 chapters at 4 repute books

kidney transplantation

Käthe B Meyer completed her Master’s and is currently completing her PhD at Oslo University. She is a Transplant Coordinator at Oslo University Hospital. She has been a member of several international committees such as the Executive Committee of the Board of Transplant Coordinators within the division of Transplantation of the UEMS, Chair of Nordic Transplant Coordinator Group and scientific committee member at EDTCO congresses. She has published 8 articles in reputed journals.

Research Interest: Transplantation and Kidney diseases

Dr. Amit Gupta is currently working as a Professor of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India. He is a Senior Resident in AIIMS New Delhi, India and fellow in Nephrology Guys Hospital, London, UK and Toronto Hospital, Toronto, Canada. He had qualifications of M.B.B.S; M.D. (Medicine), D.N.B (Nephrology) and FRCP (London). He has a 40 years of experience as a faculty member in Department of Nephrology, SGPGIMS, Lucknow, India joined in the year 1987. His main research and interest areas are Peritoneal Dialysis and Renal transplantation. He held various positions in various Societies, Past President Indian Society of Nephrology, 2009 and Past President Peritoneal Dialysis Society of India, 2004. And also he had orations in Khullar Oration of Indian Society of Nephrology 2005, Arogya Kalyan Nyas Oration of Peritoneal Dialysis Society of Nephrology 2012 and Georgi Abraham Oration of Peritoneal Dialysis Society of India 2016. He had 192 articles in indexed journals & 30 book chapters. And also he had a achievement in the CAPD programme at SGPGIMS in 1993 which is the largest centre for CAPD in South Asia.

Nephrology

Vladimirs Strazdins graduated from Riga Medical Institute in 1977 (now called Riga Stradins University). He served for two years as an Army Medical Officer and started to work in University Hospital for Children in Riga in 1983. In 1992, he was appointed as Head of Nephrology at the same hospital and held this position till 2009. He is a member of European Pediatric Dialysis Working Group under ESPN from 2004 till 2012, with published European Guidelines on Pediatric Dialysis. He is recently retired, but still working part-time in Hemodialysis Unit at MS Gailezers and provides second-opinion to the consulting patients. He currently focuses on antimicrobial resistence issues and its implications on urinary tract infections.

Dialysis and urinary tract infections.

Thomas Ryzlewicz has completed his PhD from Free University in Berlin (West). He started dialysis treatment in 1974. In between 2 years in the Physiologic Institute (Berlin-West, theme acid-base status). In1978, he published two papers in Kidney International (co-working with H Hampl) concerning the cardio-vascular behavior during dialysis monitored by left-heart catheter. In 1978, he worked on the development of a rough protoype for bicarbonate dialysis in order to study the amount of acidification. In 1985, he was a Consultant at the Nephrologic Clinic in Regensburg (Bavaria, Germany). He was a Senior Consultant in 1992 (dialysis centre in Ebersberg, near Munich, Germany). He is responsible for handling of many prototypes of dialysis supply systems, e.g., prototypes of hemofiltration (1978) and of the real (2-step) online-hemofiltration (1983-85). He worked on the development of an own bloodline with minimal contact between blood & air in order to reduce the sheer-stress in single fibre capillary (big EPO dosage reduction, product “Oxyless-Line”) which obtained EU patent, US patent, PEMA audit from London, and was published by Ian Macdougal (King’s College, London)

Dialysis, Kidney Transplantation

Prof. Petra Reinke is Nephrologist / Clinical Scientist - scientific topics: transplantation medicine, development of new diagnostic and therapeutic approaches in transplantation. She is Project coordinator for the EU founded FP7 consortium “BIO-DrIM”, was Steering committee member / work-package leader of the EU founded FP7 consortium “ONE- Study”, Steering committee member / work-package leader of the EU founded FP6 consortium “RISET”, Co-PI for a project founded by the Immune Tolerance Network, Co-Investigator ROTF grant. She is Head of the “Kidney Transplant Outpatient Clinic”; Head of research area “immune system”, Head of the GMP-Facility, Steering Committee Member of the Berlin-Brandenburg Center for Regenerative Therapies, of the DFG-sponsored Berlin-Brandenburg School for Regenerative Therapies, of the Berlin Institute of Health (BIH) Stem Cell Center. She published more than 300 articles.

Transplantation medicine

Květa Bláhová is an Associate Professor in Dpt of Pediatrics at Charler University and University Hospital Motol in Prague. She received many awards. She has membership in prestigious European societies. She has published numerous papers in reputed Journals

Chronic peritoneal dialysis, End-stage renal disease

Donald Silverberg Graduated from Medical School University of Manitoba in 1962. He did his Residency in Internal Medicine and Nephrology at the Mayo Clinic Rochester Minnesota in 1962-1966 and Residency in Nephrology, University of Lund, Sweden in 1966-1967. He worked as Nephrologist University Hospital, Edmonton Canada during l968-1976. Has been living in Israel and practicing nephrology since 1976 in Tel Hashomer and Beilinson and Tel Aviv Medical Center. National Director of Hypertension Control Division, Kupat Holim Sick Fund 1978-1986 (Organizing the detection and treatment of hypertension for the Israeli population)

Research Interest: Transplantation medicine

Bruce Hendry is President of the UK Renal Association and Emeritus Professor of Renal Medicine at King's College London. He graduated in medicine from the University of Oxford and received his PhD in Biophysics from the University of Cambridge. His major research interests are in the cell and molecular biology of progressive renal fibrosis and in the design of novel therapeutic approaches. His current work is focused on the study of new approaches to the problem of aberrant renal cell proliferation leading to fibrosis; this work includes the use of antisense and small molecule strategies. Recent work has examined the role of antisense as therapy in renal fibrosis and ADPKD and the targeting of T-type calcium channels in glomerular disease. He has clinical research interests in diabetic nephropathy, HIV and the kidney and in polycystic kidney disease

Nephrology

Dr Pearl Pai qualified from the University of Aberdeen, UK, and received her MD from the University of Liverpool. She is the Chief of Service (Department of Medicine) and Chief of Nephrologist at University of Hong Kong – Shenzhen Hospital, Guangdong, China. She is also the Honorary Clinical Associate Professor at the Department of Medicine, the University of Hong Kong. She was a NHS Consultant Physician and Nephrologist in Sunderland Royal Hospital and then Royal Liverpool University Hospital before she returned to Hong Kong in 2012

Dialysis

Dr. Andrew Lobashevsky has completed his PhD at the age of 27 years from Moscow Medical Academy, Russia and postdoctoral studies from University of Tennessee at Memphis. He is the associate professor and director of histocompatibility and transplant Immunology laboratory at Indiana University and IUHealth Inc. He has published more than 50 papers in reputed journals and has been serving as an editorial board member of 2 repute journals.

Organ Transplantation and Transplant Immunology

Dr. Naohiko Ueno is the director of Ueno Internal Medicine and Diabetes Clinic, and a visiting lecturer at Kagoshima University Graduate School of Medical. He specializes in Diabetes and certified by the Japan Diabetes Society, and also specializes in Internal Medicine certified by the Japanese Society of Internal Medicine. He received his Ph.D. in 2000 at Kobe University Graduate School of Medicine. He studied as a postdoctoral fellow at the Department of Neuroscience of the University of Florida, USA. His current field of interest is diabetes treatment and body weight regulation. He has many publications in medical journals including Diabetes Care, Diabetologia, Endocrinology and Gastroenterology.

Diabetes treatment, Endocrinology and Gastroenterology

Prof. Petra Reinke is Nephrologist / Clinical Scientist - scientific topics: transplantation medicine, development of new diagnostic and therapeutic approaches in transplantation. She is Project coordinator for the EU founded FP7 consortium “BIO-DrIM”, was Steering committee member / work-package leader of the EU founded FP7 consortium “ONE- Study”, Steering committee member / work-package leader of the EU founded FP6 consortium “RISET”, Co-PI for a project founded by the Immune Tolerance Network, Co-Investigator ROTF grant. She is Head of the “Kidney Transplant Outpatient Clinic”; Head of research area “immune system”, Head of the GMP-Facility, Steering Committee Member of the Berlin-Brandenburg Center for Regenerative Therapies, of the DFG-sponsored Berlin-Brandenburg School for Regenerative Therapies, of the Berlin Institute of Health (BIH) Stem Cell Center. She published more than 300 articles.

Transplantation medicine

Phuong-Thu Pham is Associate Clinical Professor of Medicine, Nephrology Division, David Geffen School of Medicine at UCLA and Director of Outpatient Services, Kidney Transplant Program. Her special areas of interest include new onset diabetes mellitus after transplantation, pretransplant cardiovascular screening, post-transplant cardiovascular disease, glomerular disease recurrence following transplantation, BK virus screening and management following kidney transplantation, and acute and chronic kidney injury following liver transplantation. Her interests in these topics have resulted in publications in well-known Nephrology textbooks and journals as well as invitations to speak at both national and international meetings. She has also served as a reviewer for over twenty major journals and an editorial board member for the Case Reports in Nephrology and Transplantation Technologies and Research journals.

Renal transplantation

Dr. Simit M Doshi is an Internal Medicine Specialist in Indianapolis, Indiana. He graduated with honors in 2008. Having more than 8 years of diverse experiences, especially in INTERNAL MEDICINE, NEPHROLOGY, Dr. Simit M Doshi affiliates with many hospitals including Eskenazi Health, Indiana University Health, and cooperates with other doctors and specialists in medical group University Medical Diagnostic Associates, Inc. Call Dr. Simit M Doshi on phone number (317) 948-2369 for more information and advises or to book an appointment.

Nephrology

Thomas Ryzlewicz at 66 years, born in West-Berlin (Germany). Nephrologist since 40 years with regular clinical work with RRT Patients. In 1974 he used several of the first Dialysis Set-Up’s (Travenol 120 Batch System, Milton Roy B II, Gambro AK 3). 1978 Bag-Hemofiltration done (with the Equipment of 3 Blood Pumps, one Bed Scale and a Cup to measure the Filtration Rate (with a Stop-Watch)

Nephrology

Takeo Ishii has completed his PhD at the age of 28 years from Jikei University School of Medicine, Tokyo. He is now the co-director of Yokohama Daiichi Hospital, a central hospital of Zenjinkai Group. Zenjinkai Group is consisting from 51 hemodialysis clinics and health check up centers. He is also a reserch fellow of Department of Medical Science and Cardiorenal Medicine, Yokohama City University, Graduate school of Medicine. He received award from Japanese Society of Nephrology. The award wining study was dialysis outcome study and he read this paper at EDTA-ERA 2017.

He is also a reserch fellow of Department of Medical Science and Cardiorenal Medicine, Yokohama City University, Graduate school of Medicine.

I am an Egyptian physician, Cairo University (M.D., 1994),Master in Nephrology and renal dialysis with training in Lyon – France and PhD clinically attached in Kidney transplantation from Pisa University, Italy. I also published in reputed journals. experience in nephrology, renal replacement therapies and transplantation was acquired through direct contact with excellent staff of university institutions, hospitals and dialysis centers in Egypt, France, Italy, Kuwait and Saudi Arabia

Master in Nephrology and renal dialysis

huong-Thu Pham is a Professor of Medicine and Director of Outpatient Services of the Kidney Transplant Program at UCLA Medical Center. Her major areas of interest include recurrence of glomerular diseases following primary renal transplantation, new onset diabetes after transplantation, BK virus screening andrnmanagement after kidney transplantation, the link between hypomagnesemia and renal function decline in patients with diabetes mellitus type 2 as well asrnin recipients of kidney transplant and acute and chronic kidney injury following liver transplantation. Her interests have resulted in publications in well-known Nephrology textbooks and journals as well as invitations to speak at both national and international meetings. She has written over 20 book chapters for major Nephrology and solid organ transplantation textbooks including Comprehensive Clinical Nephrology, Textbook of Organ Transplantation, Transplantation of thernLiver, Pancreas, islet and stem cell transplantation for diabetes, Chronic Kidney Disease: Dialysis and Transplantation, and Handbook of Kidney Transplantation.rnShe has also served as Moderator for transplant-related conferences at the American Society of Nephrology and World Congress of Nephrology, EditorialrnBoard Member for the Case Reports in Nephrology and Transplantation Technologies and Research journals and Member of the Organizing Committee for thernInternational Conference on Nephrology and Therapeutics.

Nephrology

Dr. Vasilyev received his Ph. D. (2001) and M.D. (2004) degrees from Rosalind Franklin University of Medicine and Science. He then completed his residency training in Anatimic Pathology at the Massachusetts General Hospital (2007) and a Research Fellowship in Renal Pathology (2009). In 2009 he became an Instructor in Pathology at the Massachusetts General Hospital/Harvard Medical School, and in 2013 started as an Assistant Professor in Biomedical Sciences at the New York Institute of Technology, College of Osteopathic Medicine. He uses zebrafish to study kidney development and regeneration.

zebrafish to study kidney development and regeneration.

Dr. Allen obtained a PhD in Medicine in 1978. For over 14 years, he worked at and subsequently headed a hospital’s cardio-vascular department, and treated patients with renal diseases. He had authored many scientific articles on metabolic disorders, including those linked to obesity, kidneys, arthritis, cardio-vascular and gastroenterological diseases. He lectured medical doctors pursuing higher medical qualifications. He then devoted nearly two decades to further medical research into various chronic internal diseases. Dr. Allen established Fine Treatment, UK, is the author of The Origin of Diseases Theory and the inventor of the effective devices which enable the Thermobalancing therapy.

Fine Treatment

Dr. Hefsa has completed her fellowship of nephrology in Sheikh khalifah medical center Abu Dhabi, United Arab Emirates in 2018 at the age of 35. She is working as a nephrologist in SKMC and activly invoved in the care of dialysis patients and kidney transpant patients. She is also working in completing her Master degree in renal transplant from liverpool university online course.

Glomerulonephritis (GN) is a rising paramount renal disease that varies in etiology from inherited or acquired factors. Its severity can range from asymptomatic depictions to end stage kidney disease (ESKD). The aim of this study was to study patterns of biopsy-proven glomerulonephritis based on data from a multicenters in Abu Dhabi. Included kidney biopsy were from all patients above the age of 18 years, over a six-year period from 2010 till 2015, who had diagnosis of glomerular disease other than diabetes mellitus. The number of reviewed biopsies was 416. The most common type of glomerulonephritis among the study sample were the IgA GN (22.8) followed by the FSGS (20.4%) followed by the SLE (19.7%). The least common types were Pauci Immune (1.7). There was female preponderance in lupus nephritis and pauci immune GN. The nationality comparison did not reveal a predominate GN among Emirati nationals. The age relationship to GN types showed that the majority (82.9%) of SLE patients, MCD (74.55 %) and non- categorized (71.4%) patients are young between the age of 18 to 39 years. On the other hand, 57.1%, 25% and 16.7% of patients with Pauci immune, other GN types and MPGN respectively are 60 years and older.

Dr. Dyjur completed her PhD in 2015 from the University of Calgary in Alberta, Canada. She is the director of Inpatient Services at Providence St. Mary Medical Center in Walla Walla, and Director of the hemodialysis program. She completed her doctoral research in the area of Nursing Work with medications using the methodology of Institutional Ethnography.

The distribution of health care services in the United States varies substantially across regions. Patients face many barriers and challenges in accessing hemodialysis in hospital, related to geophraphic variation in availability. Optimal management of end stage renal disease (ESRD) requires specialized, time sensitive care. Sparse services in rural communities and the inability to provide inpatient renal care in a timely manner can lead to increased costs, more rapid disease progression and higher mortality rates. Historically, hemodialysis services were delivered within Providence St. Mary Medical Center (PSMMC) by a contracted service provider. When contracted services were disrupted and/or unavailable, it became necessary to tranfer patients out of their home community to larger centers where critical dialysis services could be reliably provided. As disruptions began to occur on a frequent basis, a core team at PSMMC began to explore how the NxStage system could be utilized to provide hemodialysis, renal replacement and ultrafiltration therapies to inpatients.

In ten cases of live kidney donors because of difference in size and GFR of kidneys obligatory right side kidneys were selected for nephrectomy during dissecting renal vein and venae cava about 1CM in caudal and 1 cm in cephalic to renal vein on vena cava skeletonized and Stansky applied to take the vein of vena cava 1CMabove and 1 CM below of vein of renal and with a calf of 5mm in both sides, after removing kidney the kidney was placed in right iliac of kidney recipient without any trim nation of vein and donor 2 days after surgery discharged from hospital and followed after one month and then every 6 months.

Right renal vein with longitudinal flaps of vena cava and with a cuff was able to be anastomosed without tension and it was safe.

Jennifer Van Dine has recently completed her MPH in Epidemiology at The Ohio State Univeristy in 2019. She completed her culminating project on identifying risk factors for urinary tract infections among individuals with developmental disabilities to help healthcare professionals to identfy UTIs and help prevent them from occuring.

Urinary tract infections (UTIs) are one of the top causes for ambulatory visits in the United States. This is especially a problem for Ohioans with developmental disabilities. There is research about predictors for UTIs among the general population, but few studies are specific to individuals with developmental disabilities. The purpose of this study was to determine predictors for UTIs among Ohioans served at the Ohio Department of Developmental Disabilities (DODD). A total of 2489 cases and 17453 controls from the DODD met the study criteria. Data came from the DODD data warehouse and Ohio Medicaid system. Unadjusted, adjusted, and stepwise logistic regression were completed. The stepwise logistic regression found that individuals with autism had reduced odds of getting a UTI (OR=0.75; 95%CI: 0.64, 0.88; p=0.0004) while having a wheelchair increased a person’s odds (OR=1.25; 95%CI: 1.08, 1.45; p=0.0030). The odds varied for age and gender, with females younger than 55 having the highest odds when compared to males younger than 55 (OR=2.45; 95%CI: 1.84, 3.27; p<0.0001). Males who were able to pull themselves to standing had reduced odds of UTI compared to males who could not pull themselves to standing (OR=0.58; 95%CI: 0.47, 0.72; p<0.0001), but the odds of females getting a UTI were increased irrespective of ability to pull themselves to standing. These findings can help healthcare professionals identify individuals at an increased risk for UTIs, helping make a timelier diagnosis, and potential prevent UTIs from occurring.

Barrington Brevitt is a PhD candidate at the University of the West Indies (UWI), Mona Campus, Jamaica doing research in Applied Physics. He is also pursuing a Post Graduate Certificate in University Teaching and Learning. He currently possesses a Diploma in Sports Therapy, BSc in Diagnostic Imaging and an MSc in Medical Physics. Barrington is currently employed as a Senior Medical Physicist at the Kingston Public Hospital and as an adjunct assistant lecturer at UWI. He is actively involved in radiation therapy treatment planning, diagnostic and therapeutic quality assurance and staff training. Barrington has been involved in the medical use of radiation for the past 13 years; he has a passion for radiation protection and has published 4 research papers. He has participated in many local and international conferences as well as technical workshops and training with the IAEA and Varian.

The ionizing radiation employed during computed tomography (CT) imaging can result in damage to tissue, increasing the risk of cancer and genetic mutation caused by chromosomal damage. The absorbed dose, measured in Gray (Gy) describes the total radiation energy absorbed per unit mass of tissue. However to achieve a more accurate measure of radiation exposure the effective dose (ED) is considered. This is the sum of doses delivered to each organ in relation to its radio-sensitivity and susceptibility to cancer risk and genetic mutation(1). This research was conducted to determine the effective radiation dose (ED) delivered during computed tomography examinations including those to diagnose renal disease.

Dr. Hefsa has completed her fellowship of nephrology in Sheikh khalifah medical center Abu Dhabi, United Arab Emirates in 2018 at the age of 35. She is working as a nephrologist in SKMC and activly invoved in the care of dialysis patients and kidney transpant patients. She is also working in completing her Master degree in renal transplant from liverpool university online course.

Glomerulonephritis (GN) is a rising paramount renal disease that varies in etiology from inherited or acquired factors. Its severity can range from asymptomatic depictions to end stage kidney disease (ESKD). The aim of this study was to study patterns of biopsy-proven glomerulonephritis based on data from a multicenters in Abu Dhabi. Included kidney biopsy were from all patients above the age of 18 years, over a six-year period from 2010 till 2015, who had diagnosis of glomerular disease other than diabetes mellitus. The number of reviewed biopsies was 416. The most common type of glomerulonephritis among the study sample were the IgA GN (22.8) followed by the FSGS (20.4%) followed by the SLE (19.7%). The least common types were Pauci Immune (1.7). There was female preponderance in lupus nephritis and pauci immune GN. The nationality comparison did not reveal a predominate GN among Emirati nationals. The age relationship to GN types showed that the majority (82.9%) of SLE patients, MCD (74.55 %) and non- categorized (71.4%) patients are young between the age of 18 to 39 years. On the other hand, 57.1%, 25% and 16.7% of patients with Pauci immune, other GN types and MPGN respectively are 60 years and older. This study shows the histopathological variety of glomerular disease in Abu Dhabi. It could be a driving point to help understand GN better in the region.

Dr Yun Hui Sheryl Wong is currently a renal advanced trainee in Western Australia and is interested in the area of dialysis and chronic kidney disease. Ms Ann Berwick is currently a clinical pharmacist at Royal Perth Hospital. Ms Anne Ngyuen is currently a clinical pharmacist at Royal Perth Hospital Ms Kate Morley is a clinical dietician who works out from Amity Health. Prof Mark Thomas is a nephrologist at Royal Perth hospital and has been involved in more than 20 publications.

As chronic kidney disease progresses through the 5 stages, hyperphosphataemia occurs, resulting in bone demineralisation, vascular and soft tissue calcification, cardiovascular disease and secondary hyperparathyroidism. Dietary restriction of phosphate alone becomes insufficient over time to counteract this process and various phosphate binders are commonly prescribed to reduce the absorption of phosphate from the gastrointestinal tract. Magnesium based phosphate binders have been shown to be non-inferior to sevelamer for the management of hyper-phosphataemia. However, there is a vast array of commercial magnesiumbased supplements available to the Australian consumer. Considerable heterogeneity exists not only in their magnesium content, but the concentration of other additional ions like calcium, potassium and phosphate. We discuss these supplements and present them in a table. The clinician should note that caution should be exercised when prescribing these supplements, particularly to the CKD population.(137 words)

Boris Ajdinovic is the Head of Institute for the Nuclear Medicine, Military Medical Academy, Belgrade. He is a Professor and has obtained Doctor of Science degree in Nuclear Medicine. He has graduated from University of Belgrade in 1978 and has obtained Nuclear Medicine specialization. He is an Instructor of Nuclear Medicine for students specializing in internal medicine and surgery from 1985. He has over 250 specialized and scientific published articles and is the recipient of many awards and honors

Nephrology

A graduate of the National Defense Medical Center (NDMC), Kuo-Cheng Lu joined the NDMC faculty in 1985 after having training at Internal Medicine and Clinical Nephrology. He devoted the first two decades of his career to the clinical care of dialysis patients at Tri-Service General Hospital and private Kou-Cheng clinic in Taipei, Taiwan. At the same time, he conducted bone biopsy (Histomorphometric study) research for renal patients, especially on the osteitis fibrosa cystica (SHPT) and calcitriol therapy. After managing of private dialysis clinic for ten years, he moved to the Nephrology division of Cardinal-Tien Hospital, an affiliated teaching hospital of Fu-Jen Catholic University. In 2003, he was elected as the chairman of Department of Medicine, Cardinal-Tien Hospital. Since 2003, Dr. Lu’s research has moved toward translation study in renal dystrophy focusing on SHPT treatment. The most significant contributions involved an ongoing trans-disciplinary study of renal bone diseases with a goal of identifying significant differences in renal bone diseases among the different degree of turnover status. Dr. Lu also teaches at other medical schools such as Taipei Medical University and National Defense Medical Center. Moreover, Dr. Lu supervised many PhD students who study in the field of bone cell regulation in various clinical diseases. In 2015, Dr. Lu was recruited to join Fu-Jen Catholic University as Associate Dean of College of Medicine, Fu-Jen Catholic University. Since then, Dr. Lu became more interested in potential of large observational data, biology, and pathophysiology with available renal bone disorders, both at the bedside and through translation study. In Dec 2016, this effort was rewarded when he was selected as the Present of Taiwan Society of Nephrology, devoted to improve the high quality multidisciplinary care for CKD patients in Taiwan. Currently, Dr. Lu also pays attention to study on the possible AKI in the development of CKD. This work led him to organize the faculties across many medical centers in Taiwan for the study on how AKI induces CKD, which may be used to address health care quality. Over the years, Dr. Lu has had the privilege of advocating CKD healthcare education in Tanzania, China, Japan and doing research with the professionals in these counties. Dr. Lu also published papers in the field of music therapy in dialysis patients. Currently, Dr. Lu spends much time on the strengthening international collaboration among the Taiwan Society of Nephrology (TSN) and Nephrology Society of Japan, Korea, Thailand and Malaysia to enhance the academic communicate, share the clinical experience and promote CKD education programs.

Clinical Medical Education, Renal Osteodystrophy, Secondary Hyperparathyroidism (SHPT) & Vitamin-D, Dialysis